Aptevo Therapeutics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $3.7M | $1.2M | $45.0M |
| FY2022 | $1.5M | $18.0M | $22.6M |
| FY2023 | $0 | $12.2M | $16.9M |
| FY2024 | — | $4.8M | $8.7M |
| FY2025 | — | $17.4M | $21.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $3.7M | $1.2M | $45.0M |
| FY2022 | $1.5M | $18.0M | $22.6M |
| FY2023 | $0 | $12.2M | $16.9M |
| FY2024 | — | $4.8M | $8.7M |
| FY2025 | — | $17.4M | $21.6M |